12.07.2023 Limes Schlosskliniken AG  DE000A0JDBC7

EQS-Adhoc: Limes Schlosskliniken AG: LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG


 

EQS-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Expansion/Investment
Limes Schlosskliniken AG: LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG

12-Jul-2023 / 15:32 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


DGAP-Adhoc: LIMES Schlosskliniken AG:

LIMES Schlosskliniken AG acquires a stake in the Liechtenstein CLINICUM ALPINUM AG

LIMES Schlosskliniken AG, Cologne/Gaflei, FL, July 12, 2023. LIMES Schlosskliniken AG has acquired 51% of the Liechtenstein private clinic CLINICUM ALPINUM AG via a capital increase. 49% of the shares continue to be held by the founding Risch family and further Liechtenstein investors.

The CLINICUM ALPINUM has been opened in 2019 and focuses primarily on mental diseases, such as depression and stress-related disorders. The clinic is located in an alpine setting at 1,483 meters above sea level and offers an individualized treatment plan as well as high-frequency psychotherapy and a wide range of individually tailored special therapies. Nestled in the Liechtenstein mountains, the Healing-Environment-Concept for mental diseases has been implemented to the highest quality.

The CLINICUM ALPINUM and the LIMES Schlosskliniken will strengthen the international orientation of the clinic with the existing team around the chief medical officer Marc Risch. The new partnership offers all the prerequisites for this.

The capital increase by LIMES Schlosskliniken AG will be financed from liquid funds of the LIMES Group.

 

Corporate profiles:

The CLINICUM ALPINUM opened in 2019 and has been successfully positioned as a private Liechtenstein  acute clinic for the treatment of depression and stress-related diseases. The clinic, in a unique location, has a total of 50 treatment places. More information is available at www.clinicum-alpinum.com.

The LIMES Schlosskliniken Group operates high-quality private clinics in Germany for stress-related diseases, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to state aid and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de.

Your contact person:
LIMES Schlosskliniken AG, Petra Kaes, Investor Relations
Kaiser-Wilhelm-Ring 26, 50672 Cologne
Tel.: 0221/669 615 10, [email protected]

Language:  German
Company: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Cologne, Germany
Phone:   49 221 669 615 10
Mail:  [email protected]
Internet:  www.limes-schlosskliniken.de
ISIN:  DE000A0JDBC7
WKN:  AOJDBC
Stock exchange: Düsseldorf Open Market, Primary Market, XETRA

End of the message

 



End of Inside Information

12-Jul-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Limes Schlosskliniken AG
Kaiser-Wilhelm-Ring 26
50672 Köln
Germany
ISIN: DE000A0JDBC7
WKN: A0JDBC
Listed: Regulated Unofficial Market in Dusseldorf
EQS News ID: 1678729

 
End of Announcement EQS News Service

1678729  12-Jul-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1678729&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023
Umsatzerlöse1 6,54 7,43 8,18 11,02 23,44 28,81 37,17
EBITDA1,2 -0,49 -0,13 0,26 0,84 6,02 8,65 7,67
EBITDA-Marge3 -7,49 -1,75 3,18 7,62 25,68 30,02
EBIT1,4 -0,72 -0,93 -0,54 -0,43 4,53 6,00 5,03
EBIT-Marge5 -11,01 -12,52 -6,60 -3,90 19,33 20,83 13,53
Jahresüberschuss1 -1,25 -1,46 -0,83 -0,69 4,11 4,86 3,91
Netto-Marge6 -19,11 -19,65 -10,15 -6,26 17,53 16,87 10,52
Cashflow1,7 1,02 -0,66 0,17 0,76 4,77 8,04 6,29
Ergebnis je Aktie8 -4,95 -5,78 -2,81 -2,37 13,45 14,34 11,58
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: B-S-H Collegen

INVESTOR-INFORMATIONEN
©boersengefluester.de
Limes Schlosskliniken
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0JDBC 334,000 Kaufen 97,93
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
19,76 21,46 0,92 71,14
KBV KCV KUV EV/EBITDA
6,47 15,56 2,63 12,97
Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in %
Hauptversammlung
0,00 0,00 0,00 10.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
03.09.2024 13.05.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-7,78% -4,01% 17,61% 20,14%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Limes Schlosskliniken AG  ISIN: DE000A0JDBC7 können Sie bei EQS abrufen


Pflegeeinrichtungen , A0JDBC , LIK , XETR:LIK